Skip to main content
. 2018 Apr 17;9(29):20399–20408. doi: 10.18632/oncotarget.24911

Table 1. A summary of the KD data calculated for GR01 and GR02.

Ligand huGR huAR huPR huER huMR msGR rtGR
Ref. 2.03 × 10–9 4.96 × 10–10 6.27 × 10–10 6.94 × 10–9 1.41 × 10–8 ND ND
GR01 3.86 × 10–9 1.46 × 10–6 1.06 × 10–6 9.78 × 10–7 2.12 × 10–7 ND ND
GR02 1.59 × 10–8 1.26 × 10–6 2.42 × 10–7 2.07 × 10–5 4.03 × 10–6 6.71 × 10–9 6.18 × 10–9

Data were calculated with competition binding assays displacing 3H-steroid agonists for the respective human (hu), mouse (ms), and rat (rt) nuclear hormone receptor on cells. Data are reported as [M]. Reference compounds (Ref.) are positive control agonists or antagonists: dexamethasone (GR), dihydrotestosterone (AR), progesterone (PR), 4-OH-tamoxifen (ER), and eplerenone (MR). ND = not determined.